PLSE Earnings Date: Nov 5, 2026 (Estimated) — Pulse Biosciences, Inc.
NASDAQ · Healthcare · Medical Instruments & Supplies
Updated
When is PLSE's next earnings date?
Pulse Biosciences, Inc. (PLSE) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.31 on revenue of $520,833.
How did PLSE do in its last earnings report?
In its most recent report on Aug 6, 2026 (Q2 2026), Pulse Biosciences, Inc. posted EPS of -$0.36 versus the -$0.31 estimate, a miss of 24.1%. Revenue was $434,000 against a $500,000 estimate. The stock's 1-day post-earnings move was +10.9%.
How much does PLSE stock move after earnings?
PLSE beat EPS estimates in 1 of its last 5 reported quarters. Over the last 8 reports the stock moved an average of 8.4% (up or down) in the day after earnings.
About Pulse Biosciences, Inc.
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q2 2026 | -0.31 | -0.36 | -24.14% | $434,000 | ❌ Miss | +10.90% | +17.47% | +39.23% |
| 2026-05-04 | Q1 2026 | -0.24 | -0.27 | -12.50% | $401,000 | ❌ Miss | -3.84% | -8.40% | +16.56% |
| 2026-02-19 | Q4 2025 | -0.25 | -0.26 | -4.00% | $264,000 | ❌ Miss | -14.59% | -23.09% | -11.88% |
| 2025-11-05 | Q3 2025 | -0.31 | -0.29 | +6.45% | $86,000 | ✅ Beat | -3.32% | -7.81% | -18.44% |
| 2025-08-12 | Q2 2025 | -0.26 | -0.28 | -7.69% | $0 | ❌ Miss | +11.19% | +5.03% | +0.00% |
| 2025-03-27 | Q4 2024 | — | -0.17 | — | $0 | — | +6.00% | -7.22% | +14.62% |
| 2024-08-12 | Q2 2024 | — | -0.20 | — | $0 | — | +8.05% | +27.54% | +9.52% |
| 2024-05-07 | Q1 2024 | — | -0.15 | — | $0 | — | -9.21% | +1.18% | +91.38% |
Showing last 8 quarters.
Revenue by segment & region
By region
FY2022 · $700K total · annual
| Segment | Share | Revenue | YoY |
|---|---|---|---|
| North America | 73.9% | $517K | — |
| Rest of World | 26.1% | $183K | — |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.